TAM+DUT

Tamsulosin + Dutasteride — Modified-Release Capsule

Alpha-1 blocker + 5α-reductase inhibitor • Oral capsule • Rx-only
Prescription-only medicine.
Educational overview of the fixed-dose combination: approved indications, brand examples, safety considerations, and official references.
Always follow your local approved leaflet and clinician guidance.

🩺
Combination therapy for moderate–severe BPH
Symptom relief + prostate volume reduction under medical supervision
✅ Rx-only
✅ Fixed-dose combo
✅ Label-first

📦 Product Snapshot

Active substancesTamsulosin + Dutasteride
Typical strength0.4 mg / 0.5 mg
Dosage formModified-release oral capsule
Exact strength combinations and capsule technology may vary by market. Confirm leaflet and on-pack details.
Reference brandDuodart®
India brand examplesUrimax D® / Dutaster-T® / Combodart® (examples)
Typical indicationBenign prostatic hyperplasia (BPH)
Indicated in many countries for men with moderate to severe BPH symptoms and enlarged prostate.
Approved wording differs by jurisdiction.

Request verified information
Use our inquiry form to request official leaflet links, confirm available strengths, and verify general packaging or authenticity details.
We do not provide medical advice.

International visitors: informational support is available for users in the United States,
United Kingdom, and Australia.


✉️
Request Information

Rx-only • label-first • verify local guidance

🧠 Overview

The fixed-dose combination of tamsulosin (an alpha-1 adrenergic receptor antagonist) and dutasteride (a dual 5α-reductase inhibitor)
targets two different mechanisms involved in benign prostatic hyperplasia (BPH).

Tamsulosin relaxes smooth muscle in the prostate and bladder neck, which may improve urinary flow and reduce lower urinary tract symptoms.
Dutasteride reduces dihydrotestosterone (DHT) levels, contributing to gradual reduction in prostate volume over time.

Combination therapy is generally considered in men with enlarged prostate and persistent or progressive symptoms.
PSA interpretation, contraindications, and monitoring requirements are label-dependent and require clinician oversight.

🏷️ Strengths & Brand Examples

Common fixed strength
  • Tamsulosin 0.4 mg + Dutasteride 0.5 mg (most common combination)
Brand examples
  • Duodart®
  • Urimax D®
  • Other market-specific generics
Brand names are illustrative examples. Availability and manufacturer details may change; verify current regulatory status and labeling.

⚠️ Safety, Side Effects & Monitoring

Commonly discussed effects
  • Dizziness or orthostatic hypotension
  • Decreased libido or erectile dysfunction
  • Ejaculation disorders
  • Breast tenderness (due to dutasteride component)
Label-first warnings
Capsules should not be handled by pregnant women due to dutasteride exposure risk.
Tamsulosin may increase risk of dizziness, particularly at treatment initiation.
PSA levels can be reduced by dutasteride and must be interpreted accordingly.
Review full contraindications and precautions in the official leaflet before use.
No dosing instructions here
Dosing frequency and treatment duration are determined by a clinician based on symptom severity, prostate size,
and patient-specific factors. This page intentionally avoids dosing schedules.

❓ FAQ

Why use combination therapy instead of a single medicine?
The combination targets both symptom relief (tamsulosin) and underlying prostate enlargement (dutasteride).
It may be considered in men with moderate to severe BPH and enlarged prostate, depending on clinical assessment.
Does it affect PSA testing?
Yes. Dutasteride lowers PSA levels. Healthcare providers adjust interpretation accordingly during prostate cancer screening.
Is monitoring required?
Clinical follow-up is recommended to assess symptom response, blood pressure tolerance, and PSA trends.
Always follow your clinician’s advice and the official leaflet.

Submit your review
1
2
3
4
5
Submit
     
Cancel

Create your own review

Generic Jalyn
Average rating:  
 0 reviews